Seroprevalence of measles and natural rubella antibodies among children in Bangui, Central African Republic View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2011-12

AUTHORS

Alexandre Manirakiza, Jean Marie Kipela, Stephen Sosler, Régis M'Bary Daba, Ionela Gouandjika-Vasilache

ABSTRACT

BACKGROUND: Passively acquired maternal antibodies are necessary to protect infants against circulating measles virus until they reach the eligible age of vaccination. Likewise, high levels of population immunity must be achieved and maintained to reduce measles virus transmission. This study was undertaken to (1) assess the presence of maternally acquired measles-specific IgG antibodies among infants less than 9 months of age in Bangui, Central African Republic and (2) determine the immune status of vaccination-age children and the concordance with reported vaccination status. A secondary objective was to describe the presence of rubella-specific IgG antibody in the study population. METHODS: Vaccination history and blood samples were collected from 395 children using blotting paper. Samples were analyzed for the presence of measles-specific IgG antibodies using commercial ELISA kits. RESULTS: Measles-specific IgG antibodies were detected in 51.3% of vaccinated children and 27.6% of non-vaccinated children. Maternally derived measles IgG antibodies were present in only 14.8% of infants aged 0-3 months and were absent in all infants aged 4-8 months. The presence of IgG-specific measles antibodies varied among children of vaccination age, from 57.3% for children aged 9 months to 5 years, to 50.6% for children aged 6-9 years and 45.6% for chidren aged 10 years and above. The overall prevalence of rubella-specific IgG was 55.4%, with a high prevalence (87.4%) among children over 10 years of age. CONCLUSION: The findings suggest that despite efforts to accelerate measles control by giving a second dose of measles vaccine, a large number of children remain susceptible to measles virus. Further research is required to determine the geographic extent of immunity gaps and the factors that influence immunity to measles virus in the Central African Republic. More... »

PAGES

327

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/1471-2458-11-327

DOI

http://dx.doi.org/10.1186/1471-2458-11-327

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1049592674

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/21586151


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1117", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Public Health and Health Services", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antibodies, Viral", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Central African Republic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Child", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Child, Preschool", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Immunization Programs", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Immunoglobulin G", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Infant", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Measles", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Seroepidemiologic Studies", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Institut Pasteur de Bangui", 
          "id": "https://www.grid.ac/institutes/grid.418512.b", 
          "name": [
            "Institut Pasteur de Bangui, R\u00e9seau International des Instituts Pasteur, BP 923, Bangui, Central African Republic"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Manirakiza", 
        "givenName": "Alexandre", 
        "id": "sg:person.0641720260.05", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0641720260.05"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "World Health Organization, Libreville, Gabon"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kipela", 
        "givenName": "Jean Marie", 
        "id": "sg:person.01147373054.55", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01147373054.55"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "World Health Organization - India", 
          "id": "https://www.grid.ac/institutes/grid.417256.3", 
          "name": [
            "World Health Organization, New Delhi, India"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sosler", 
        "givenName": "Stephen", 
        "id": "sg:person.0635645134.33", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0635645134.33"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "World Health Organization, Bangui, Central African Republic"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Daba", 
        "givenName": "R\u00e9gis M'Bary", 
        "id": "sg:person.01263621454.50", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01263621454.50"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Institut Pasteur de Bangui", 
          "id": "https://www.grid.ac/institutes/grid.418512.b", 
          "name": [
            "Institut Pasteur de Bangui, R\u00e9seau International des Instituts Pasteur, BP 923, Bangui, Central African Republic"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Gouandjika-Vasilache", 
        "givenName": "Ionela", 
        "id": "sg:person.01153631700.30", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01153631700.30"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1097/00006454-200007000-00010", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011676082"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00006454-200007000-00010", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011676082"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejm198508293130904", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016908355"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1365-3083.2006.01857.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037054176"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/ije/18.1.264", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1059674025"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1074864232", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.4269/ajtmh.2005.73.26", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1077080133"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1077950307", 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2011-12", 
    "datePublishedReg": "2011-12-01", 
    "description": "BACKGROUND: Passively acquired maternal antibodies are necessary to protect infants against circulating measles virus until they reach the eligible age of vaccination. Likewise, high levels of population immunity must be achieved and maintained to reduce measles virus transmission. This study was undertaken to (1) assess the presence of maternally acquired measles-specific IgG antibodies among infants less than 9 months of age in Bangui, Central African Republic and (2) determine the immune status of vaccination-age children and the concordance with reported vaccination status. A secondary objective was to describe the presence of rubella-specific IgG antibody in the study population.\nMETHODS: Vaccination history and blood samples were collected from 395 children using blotting paper. Samples were analyzed for the presence of measles-specific IgG antibodies using commercial ELISA kits.\nRESULTS: Measles-specific IgG antibodies were detected in 51.3% of vaccinated children and 27.6% of non-vaccinated children. Maternally derived measles IgG antibodies were present in only 14.8% of infants aged 0-3 months and were absent in all infants aged 4-8 months. The presence of IgG-specific measles antibodies varied among children of vaccination age, from 57.3% for children aged 9 months to 5 years, to 50.6% for children aged 6-9 years and 45.6% for chidren aged 10 years and above. The overall prevalence of rubella-specific IgG was 55.4%, with a high prevalence (87.4%) among children over 10 years of age.\nCONCLUSION: The findings suggest that despite efforts to accelerate measles control by giving a second dose of measles vaccine, a large number of children remain susceptible to measles virus. Further research is required to determine the geographic extent of immunity gaps and the factors that influence immunity to measles virus in the Central African Republic.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1186/1471-2458-11-327", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1024954", 
        "issn": [
          "1471-2458"
        ], 
        "name": "BMC Public Health", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "11"
      }
    ], 
    "name": "Seroprevalence of measles and natural rubella antibodies among children in Bangui, Central African Republic", 
    "pagination": "327", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "ec3efa0e0e4ab640ab7a39f9821d1c269e0fc413b038c8836ccabbbcde914e9c"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "21586151"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "100968562"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/1471-2458-11-327"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1049592674"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/1471-2458-11-327", 
      "https://app.dimensions.ai/details/publication/pub.1049592674"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T23:32", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8693_00000551.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1186%2F1471-2458-11-327"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/1471-2458-11-327'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/1471-2458-11-327'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/1471-2458-11-327'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/1471-2458-11-327'


 

This table displays all metadata directly associated to this object as RDF triples.

170 TRIPLES      21 PREDICATES      48 URIs      33 LITERALS      21 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/1471-2458-11-327 schema:about N0302c3a2b1324266965a7e8edf9f52b0
2 N13c1bb37bde34b4caf196d4be1aae8e8
3 N4c3d5550a09645a5857358d7bb3983e7
4 N596088a575b749cf8964a08a943171fc
5 N5a25e0f202f643398f349b742dfb1387
6 N717d468e42a34866bb3c98a0c92dce1e
7 Na8a91df48f4746ef97537bed538eef0e
8 Nafc1956ec64f40e8818dc137eea33066
9 Nd2b4fa9f5bf842c8866a6701ca96cd8e
10 Nda1c2bc81e8d4028b55d4f8259566508
11 Nf36a46e3ec3645999b7a090b41afb3f2
12 Nf7e643019b654ccaac58237f998a0adf
13 anzsrc-for:11
14 anzsrc-for:1117
15 schema:author N185146ba2d344533b9701df05c779ed6
16 schema:citation https://app.dimensions.ai/details/publication/pub.1074864232
17 https://app.dimensions.ai/details/publication/pub.1077950307
18 https://doi.org/10.1056/nejm198508293130904
19 https://doi.org/10.1093/ije/18.1.264
20 https://doi.org/10.1097/00006454-200007000-00010
21 https://doi.org/10.1111/j.1365-3083.2006.01857.x
22 https://doi.org/10.4269/ajtmh.2005.73.26
23 schema:datePublished 2011-12
24 schema:datePublishedReg 2011-12-01
25 schema:description BACKGROUND: Passively acquired maternal antibodies are necessary to protect infants against circulating measles virus until they reach the eligible age of vaccination. Likewise, high levels of population immunity must be achieved and maintained to reduce measles virus transmission. This study was undertaken to (1) assess the presence of maternally acquired measles-specific IgG antibodies among infants less than 9 months of age in Bangui, Central African Republic and (2) determine the immune status of vaccination-age children and the concordance with reported vaccination status. A secondary objective was to describe the presence of rubella-specific IgG antibody in the study population. METHODS: Vaccination history and blood samples were collected from 395 children using blotting paper. Samples were analyzed for the presence of measles-specific IgG antibodies using commercial ELISA kits. RESULTS: Measles-specific IgG antibodies were detected in 51.3% of vaccinated children and 27.6% of non-vaccinated children. Maternally derived measles IgG antibodies were present in only 14.8% of infants aged 0-3 months and were absent in all infants aged 4-8 months. The presence of IgG-specific measles antibodies varied among children of vaccination age, from 57.3% for children aged 9 months to 5 years, to 50.6% for children aged 6-9 years and 45.6% for chidren aged 10 years and above. The overall prevalence of rubella-specific IgG was 55.4%, with a high prevalence (87.4%) among children over 10 years of age. CONCLUSION: The findings suggest that despite efforts to accelerate measles control by giving a second dose of measles vaccine, a large number of children remain susceptible to measles virus. Further research is required to determine the geographic extent of immunity gaps and the factors that influence immunity to measles virus in the Central African Republic.
26 schema:genre research_article
27 schema:inLanguage en
28 schema:isAccessibleForFree true
29 schema:isPartOf N4df7fa1860884756ae5cf3be0ddd55b9
30 Nf6b63a5d28b44cecaed49d139d031504
31 sg:journal.1024954
32 schema:name Seroprevalence of measles and natural rubella antibodies among children in Bangui, Central African Republic
33 schema:pagination 327
34 schema:productId N197704377fa64addb09db62f493e7d47
35 N61c27d55e5d44a01a49a5faedbc799d3
36 Na66cf76a7632450383c3420e66231dd4
37 Nd21466f488f04c92a395b2edc87682d9
38 Ne09c0c20386d4fc292fcd1a2cefe3324
39 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049592674
40 https://doi.org/10.1186/1471-2458-11-327
41 schema:sdDatePublished 2019-04-10T23:32
42 schema:sdLicense https://scigraph.springernature.com/explorer/license/
43 schema:sdPublisher N0d3eb4d0f79d4fa8ab08a1b6e7d2f510
44 schema:url http://link.springer.com/10.1186%2F1471-2458-11-327
45 sgo:license sg:explorer/license/
46 sgo:sdDataset articles
47 rdf:type schema:ScholarlyArticle
48 N0302c3a2b1324266965a7e8edf9f52b0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
49 schema:name Immunoglobulin G
50 rdf:type schema:DefinedTerm
51 N0d3eb4d0f79d4fa8ab08a1b6e7d2f510 schema:name Springer Nature - SN SciGraph project
52 rdf:type schema:Organization
53 N13c1bb37bde34b4caf196d4be1aae8e8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
54 schema:name Male
55 rdf:type schema:DefinedTerm
56 N185146ba2d344533b9701df05c779ed6 rdf:first sg:person.0641720260.05
57 rdf:rest N93e785c467c04847894d65d0a6b127cb
58 N197704377fa64addb09db62f493e7d47 schema:name pubmed_id
59 schema:value 21586151
60 rdf:type schema:PropertyValue
61 N43e8229f8ada4a8ba08aefb671d06e73 rdf:first sg:person.01263621454.50
62 rdf:rest N6a06333c7e754629be779b01013bf84a
63 N4c3d5550a09645a5857358d7bb3983e7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
64 schema:name Infant
65 rdf:type schema:DefinedTerm
66 N4df7fa1860884756ae5cf3be0ddd55b9 schema:issueNumber 1
67 rdf:type schema:PublicationIssue
68 N596088a575b749cf8964a08a943171fc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
69 schema:name Child, Preschool
70 rdf:type schema:DefinedTerm
71 N5a25e0f202f643398f349b742dfb1387 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
72 schema:name Child
73 rdf:type schema:DefinedTerm
74 N61020ab3e90a41e9b3ec75212e5bf4ca schema:name World Health Organization, Bangui, Central African Republic
75 rdf:type schema:Organization
76 N61c27d55e5d44a01a49a5faedbc799d3 schema:name dimensions_id
77 schema:value pub.1049592674
78 rdf:type schema:PropertyValue
79 N6a06333c7e754629be779b01013bf84a rdf:first sg:person.01153631700.30
80 rdf:rest rdf:nil
81 N717d468e42a34866bb3c98a0c92dce1e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
82 schema:name Immunization Programs
83 rdf:type schema:DefinedTerm
84 N93e785c467c04847894d65d0a6b127cb rdf:first sg:person.01147373054.55
85 rdf:rest Ncaea192025d841228a723ce9b1b1cafe
86 Na66cf76a7632450383c3420e66231dd4 schema:name doi
87 schema:value 10.1186/1471-2458-11-327
88 rdf:type schema:PropertyValue
89 Na8a91df48f4746ef97537bed538eef0e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
90 schema:name Female
91 rdf:type schema:DefinedTerm
92 Nafc1956ec64f40e8818dc137eea33066 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
93 schema:name Central African Republic
94 rdf:type schema:DefinedTerm
95 Nc28f6660591949da9cd6338f7071b75a schema:name World Health Organization, Libreville, Gabon
96 rdf:type schema:Organization
97 Ncaea192025d841228a723ce9b1b1cafe rdf:first sg:person.0635645134.33
98 rdf:rest N43e8229f8ada4a8ba08aefb671d06e73
99 Nd21466f488f04c92a395b2edc87682d9 schema:name readcube_id
100 schema:value ec3efa0e0e4ab640ab7a39f9821d1c269e0fc413b038c8836ccabbbcde914e9c
101 rdf:type schema:PropertyValue
102 Nd2b4fa9f5bf842c8866a6701ca96cd8e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
103 schema:name Seroepidemiologic Studies
104 rdf:type schema:DefinedTerm
105 Nda1c2bc81e8d4028b55d4f8259566508 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
106 schema:name Antibodies, Viral
107 rdf:type schema:DefinedTerm
108 Ne09c0c20386d4fc292fcd1a2cefe3324 schema:name nlm_unique_id
109 schema:value 100968562
110 rdf:type schema:PropertyValue
111 Nf36a46e3ec3645999b7a090b41afb3f2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
112 schema:name Measles
113 rdf:type schema:DefinedTerm
114 Nf6b63a5d28b44cecaed49d139d031504 schema:volumeNumber 11
115 rdf:type schema:PublicationVolume
116 Nf7e643019b654ccaac58237f998a0adf schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
117 schema:name Humans
118 rdf:type schema:DefinedTerm
119 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
120 schema:name Medical and Health Sciences
121 rdf:type schema:DefinedTerm
122 anzsrc-for:1117 schema:inDefinedTermSet anzsrc-for:
123 schema:name Public Health and Health Services
124 rdf:type schema:DefinedTerm
125 sg:journal.1024954 schema:issn 1471-2458
126 schema:name BMC Public Health
127 rdf:type schema:Periodical
128 sg:person.01147373054.55 schema:affiliation Nc28f6660591949da9cd6338f7071b75a
129 schema:familyName Kipela
130 schema:givenName Jean Marie
131 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01147373054.55
132 rdf:type schema:Person
133 sg:person.01153631700.30 schema:affiliation https://www.grid.ac/institutes/grid.418512.b
134 schema:familyName Gouandjika-Vasilache
135 schema:givenName Ionela
136 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01153631700.30
137 rdf:type schema:Person
138 sg:person.01263621454.50 schema:affiliation N61020ab3e90a41e9b3ec75212e5bf4ca
139 schema:familyName Daba
140 schema:givenName Régis M'Bary
141 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01263621454.50
142 rdf:type schema:Person
143 sg:person.0635645134.33 schema:affiliation https://www.grid.ac/institutes/grid.417256.3
144 schema:familyName Sosler
145 schema:givenName Stephen
146 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0635645134.33
147 rdf:type schema:Person
148 sg:person.0641720260.05 schema:affiliation https://www.grid.ac/institutes/grid.418512.b
149 schema:familyName Manirakiza
150 schema:givenName Alexandre
151 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0641720260.05
152 rdf:type schema:Person
153 https://app.dimensions.ai/details/publication/pub.1074864232 schema:CreativeWork
154 https://app.dimensions.ai/details/publication/pub.1077950307 schema:CreativeWork
155 https://doi.org/10.1056/nejm198508293130904 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016908355
156 rdf:type schema:CreativeWork
157 https://doi.org/10.1093/ije/18.1.264 schema:sameAs https://app.dimensions.ai/details/publication/pub.1059674025
158 rdf:type schema:CreativeWork
159 https://doi.org/10.1097/00006454-200007000-00010 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011676082
160 rdf:type schema:CreativeWork
161 https://doi.org/10.1111/j.1365-3083.2006.01857.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1037054176
162 rdf:type schema:CreativeWork
163 https://doi.org/10.4269/ajtmh.2005.73.26 schema:sameAs https://app.dimensions.ai/details/publication/pub.1077080133
164 rdf:type schema:CreativeWork
165 https://www.grid.ac/institutes/grid.417256.3 schema:alternateName World Health Organization - India
166 schema:name World Health Organization, New Delhi, India
167 rdf:type schema:Organization
168 https://www.grid.ac/institutes/grid.418512.b schema:alternateName Institut Pasteur de Bangui
169 schema:name Institut Pasteur de Bangui, Réseau International des Instituts Pasteur, BP 923, Bangui, Central African Republic
170 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...